Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

Amgen image

Amgen and Novartis start cancer immunotherapy push

January 7, 2015
Research and Development, Sales and Marketing Amgen, Caribou Biosciences, Intellia Therapeutics, Novartis, kite pharma

Amgen and Novartis have launched new licensing agreements with biotech companies that they hope will lead to the development of …

News
Afinitor image

Mixed bag for Novartis and Astellas in breast cancer

December 15, 2014
Research and Development, Sales and Marketing Afinitor, Astellas, Novartis, Xtandi, enzalutamide, everolimus

Preliminary results from a Phase II trial of Astellas’ Xtandi (enzalutamide) show positive benefits for the prostate cancer drug when …

News
Joe Jimenez image

EFPIA gives president role to Novartis chief executive

December 10, 2014
Medical Communications, Sales and Marketing EFPIA, Novartis, Sanofi, Witty, garidel, joe jimenez, oschmann

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has named Novartis chief executive Joe Jimenez as its new president. …

News
Sandoz image

Novartis biosimilar rivals Amgen offering

December 9, 2014
Sales and Marketing Amgen, Neupogen, Novartis, Sandoz, filgrastim, zarzio

An investigational biosimilar by Novartis’ generic pharma arm Sandoz has been found to have comparable safety and efficacy readings to …

News
Merck image

Updated: Merck buys antibiotics specialist Cubist

December 8, 2014
Sales and Marketing Antibiotics, Merck, Novartis, cubicin, cubist, eumer

Merck has purchased US antibiotics maker Cubist in a deal valued at $9.5 billion. The acquisition values Cubist at around …

News
Novartis image

Novartis flu vaccine cleared following safety probe

December 3, 2014
Sales and Marketing GSK, Novartis, Vaccine, flu, fluad

The Italian drugs safety agency has cleared the Novartis influenza vaccine Fluad, after an investigation found the vaccine was not …

News

Priority review for Novartis myeloma drug

November 26, 2014
Sales and Marketing FDA, Farydak, Novartis, daratumumab, elotuzumab, myeloma, odac

Novartis’ multiple myeloma treatment Farydak has been given an extended review by the FDA after its future seemed in jeopardy …

News

Future bleak for Novartis’ myeloma drug

November 21, 2014
Medical Communications FDA, Farydak, Novartis, ixazomib, myeloma, panobinostat

Novartis suffered a major disappointment with the negative FDA panel vote for multiple myeloma candidate Farydak earlier this month, but …

News

NICE wants more Xolair data

November 19, 2014
Sales and Marketing Genentech, NHS, NICE, Novartis, UK, Xolair, hives, omalizumab

 Novartis has been asked in draft guidance to give NICE more information before the watchdog can recommend its veteran asthma …

News
Novartis image

Novartis to present inflammatory data

November 10, 2014
Business Services AS, Novartis, PSA, Secukinumab, acr

Novartis is to present data from four pivotal Phase III trials in two debilitating inflammatory diseases at the American College …

News

Novartis signs $90m deal with Oxford BioMedica

October 10, 2014
Manufacturing and Production, Research and Development, Sales and Marketing CART-019, Novartis, Oxford BioMedica, immunotherapy, oxb

UK-based biotech Oxford BioMedica is working with Novartis in a transformational deal for the firm worth $90 million to develop …

News
Novartis image

Novartis says three executives departing firm

October 9, 2014
Medical Communications, Sales and Marketing Andrin Oswald, Brian McNamara, GSK, George Gunn, Novartis, lilly, oncology, vaccines

Swiss pharma giant Novartis has announced three of its executives are to leave the firm following deals with Lilly and …

News

Bexsero and Sirturo clear winners at UK Prix Galien Awards

October 2, 2014
Medical Communications, Research and Development, Sales and Marketing 2014, Bexsero, Janssen, Novartis, awards, prix galien, sirturo

The first TB medication to be approved in four decades and the first ever vaccine to treat invasive meningococcal disease …

News

Novartis: digital pharma company of the year

September 26, 2014
Medical Communications, Sales and Marketing London, McCann Manchester and Red Door Communications, Novartis, pm society

Novartis pipped Bayer and its big pharma rivals Boehringer, Genentech, GSK and Sanofi to the post in receiving the first …

News
Boehringer image

Boehringer to slash 600 jobs in native Germany

September 24, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AMNOG, Boehringer, Germany, Novartis, cuts, mergers, staff

Boehringer Ingelheim is to cut around 600 of its staff in Germany as part of a drive to reduce costs …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025